Cargando…

COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain

OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Peremiquel-Trillas, Paula, Saura-Lázaro, Anna, Benavente-Moreno, Yolanda, Casabonne, Delphine, Loureiro, Eva, Cabrera, Sandra, Duran, Angela, Garrote, Lidia, Brao, Immaculada, Trelis, Jordi, Galán, Maica, Soler, Francesc, Julià, Joaquim, Cortasa, Dolça, Domínguez, Maria Ángeles, Albasanz-Puig, Adaia, Gudiol, Carlota, Ramírez-Tarruella, Dolors, Muniesa, Joan, Rivas, Juan Pedro, Muñoz-Montplet, Carles, Sedano, Ana, Plans, Àngel, Calvo-Cerrada, Beatriz, Calle, Candela, Clopés, Ana, Carnicer-Pont, Dolors, Alemany, Laia, Fernández, Esteve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023852/
https://www.ncbi.nlm.nih.gov/pubmed/35450905
http://dx.doi.org/10.1136/bmjopen-2021-056637
_version_ 1784690430316642304
author Peremiquel-Trillas, Paula
Saura-Lázaro, Anna
Benavente-Moreno, Yolanda
Casabonne, Delphine
Loureiro, Eva
Cabrera, Sandra
Duran, Angela
Garrote, Lidia
Brao, Immaculada
Trelis, Jordi
Galán, Maica
Soler, Francesc
Julià, Joaquim
Cortasa, Dolça
Domínguez, Maria Ángeles
Albasanz-Puig, Adaia
Gudiol, Carlota
Ramírez-Tarruella, Dolors
Muniesa, Joan
Rivas, Juan Pedro
Muñoz-Montplet, Carles
Sedano, Ana
Plans, Àngel
Calvo-Cerrada, Beatriz
Calle, Candela
Clopés, Ana
Carnicer-Pont, Dolors
Alemany, Laia
Fernández, Esteve
author_facet Peremiquel-Trillas, Paula
Saura-Lázaro, Anna
Benavente-Moreno, Yolanda
Casabonne, Delphine
Loureiro, Eva
Cabrera, Sandra
Duran, Angela
Garrote, Lidia
Brao, Immaculada
Trelis, Jordi
Galán, Maica
Soler, Francesc
Julià, Joaquim
Cortasa, Dolça
Domínguez, Maria Ángeles
Albasanz-Puig, Adaia
Gudiol, Carlota
Ramírez-Tarruella, Dolors
Muniesa, Joan
Rivas, Juan Pedro
Muñoz-Montplet, Carles
Sedano, Ana
Plans, Àngel
Calvo-Cerrada, Beatriz
Calle, Candela
Clopés, Ana
Carnicer-Pont, Dolors
Alemany, Laia
Fernández, Esteve
author_sort Peremiquel-Trillas, Paula
collection PubMed
description OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020–26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d’Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25–p75: 34.8–51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d’Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental.
format Online
Article
Text
id pubmed-9023852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90238522022-04-22 COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain Peremiquel-Trillas, Paula Saura-Lázaro, Anna Benavente-Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez, Maria Ángeles Albasanz-Puig, Adaia Gudiol, Carlota Ramírez-Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz-Montplet, Carles Sedano, Ana Plans, Àngel Calvo-Cerrada, Beatriz Calle, Candela Clopés, Ana Carnicer-Pont, Dolors Alemany, Laia Fernández, Esteve BMJ Open Epidemiology OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020–26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d’Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25–p75: 34.8–51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d’Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental. BMJ Publishing Group 2022-04-21 /pmc/articles/PMC9023852/ /pubmed/35450905 http://dx.doi.org/10.1136/bmjopen-2021-056637 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Peremiquel-Trillas, Paula
Saura-Lázaro, Anna
Benavente-Moreno, Yolanda
Casabonne, Delphine
Loureiro, Eva
Cabrera, Sandra
Duran, Angela
Garrote, Lidia
Brao, Immaculada
Trelis, Jordi
Galán, Maica
Soler, Francesc
Julià, Joaquim
Cortasa, Dolça
Domínguez, Maria Ángeles
Albasanz-Puig, Adaia
Gudiol, Carlota
Ramírez-Tarruella, Dolors
Muniesa, Joan
Rivas, Juan Pedro
Muñoz-Montplet, Carles
Sedano, Ana
Plans, Àngel
Calvo-Cerrada, Beatriz
Calle, Candela
Clopés, Ana
Carnicer-Pont, Dolors
Alemany, Laia
Fernández, Esteve
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title_full COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title_fullStr COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title_full_unstemmed COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title_short COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain
title_sort covid-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in catalonia, spain
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023852/
https://www.ncbi.nlm.nih.gov/pubmed/35450905
http://dx.doi.org/10.1136/bmjopen-2021-056637
work_keys_str_mv AT peremiqueltrillaspaula covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT sauralazaroanna covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT benaventemorenoyolanda covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT casabonnedelphine covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT loureiroeva covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT cabrerasandra covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT duranangela covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT garrotelidia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT braoimmaculada covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT trelisjordi covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT galanmaica covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT solerfrancesc covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT juliajoaquim covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT cortasadolca covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT dominguezmariaangeles covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT albasanzpuigadaia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT gudiolcarlota covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT ramireztarruelladolors covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT muniesajoan covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT rivasjuanpedro covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT munozmontpletcarles covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT sedanoana covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT plansangel covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT calvocerradabeatriz covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT callecandela covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT clopesana covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT carnicerpontdolors covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT alemanylaia covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain
AT fernandezesteve covid19amongworkersofacomprehensivecancercentrebetweenfirstandsecondepidemicwaves2020aseroprevalencestudyincataloniaspain